Evidence map›Paper›PMID 29623469›Full record

ReviewVirchows Archiv : an international journal of pathology2018

Role of ancillary techniques in profiling unclassified laryngeal malignancies.

H Hellquist, J L Hunt, A Cardesa, A Skalova, P J Slootweg, A Rinaldo, A Ferlito

Abstract readReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 6 countries.

H HellquistCBMR, Centre for Biomedical Research, University of Algarve, Edificio 2, Ala Norte, University of Algarve, 8005-139, Faro, Portugal. henrikhellquist@gmail.com.ORCID http://orcid.org/0000-0003-3044-6065
J L HuntDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
A CardesaDepartment of Anatomic Pathology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
A SkalovaDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic.
P J SlootwegDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
A RinaldoUniversity of Udine School of Medicine, Udine, Italy.
A FerlitoCoordinator of the International Head and Neck Scientific Group, Padua, Italy.
Algarve Biomedical Center · PTCharles University · CZRadboud University Nijmegen · NLUniversitat de Barcelona · ESUniversity of Arkansas for Medical Sciences · USUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laryngeal biopsies, contrary to biopsies from many other sites of the body, very often contain minute amounts of tumour tissue that may consist of morphologically undifferentiated tumour only. In haematoxylin- and eosin-stained sections, there may be no indicative features of what specific tumour entity that is present. In the larynx, particularly small round cell neoplasms, primary or metastatic, often cause a diagnostic dilemma and where an incorrect diagnosis can induce substantial clinical consequences for the patient (e.g., primary neuroendocrine carcinomas vs metastatic variants, certain sarcomas). If sufficient/representative material has been obtained, the application of immunohistochemistry and/or molecular techniques should in virtually every case reveal the true nature of the malignancy. In cases with sparse amount of material, and therefore a limited number of sections to be cut, a careful and thoughtful stepwise approach is necessary to ascertain a reliable diagnosis, or at least guide the clinician to the most likely diagnoses. With today's advanced and widely available technology with an abundance of markers to discriminate different tumours, the use of the term "undifferentiated" should be largely unnecessary. In the exceptional, and indeed exceedingly rare cases, when a classification is not possible, even after repeat biopsy, we suggest that the laryngeal neoplasm is better termed "unclassified malignant neoplasm" rather than "undifferentiated malignant neoplasm".

Indexed as

HumansLaryngeal NeoplasmsFISHImmunohistochemistryLarynxRT-PCRUnclassified malignancies

Identifiers

PMID29623469
OpenAlexW2795844535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.